Showing results (1141-1150 of 3,621) with videos related to

Sort By:
Pageof 363
Biopolymers|February 17, 2001
A helical capping motif in ShK toxin and its role in helix stabilizationM D Lanigan, J E Tudor, M W Pennington, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 11, 2000
Complexes of acridine and 9-chloroacridine with I2: formation of unusual I6 chains through charge-transfer interactions involving amphoteric I2E L Rimmer, R D Bailey, T W Hanks, et al.
The Journal of Biological Chemistry|August 15, 1993
Polyamine-like actions of peptides derived from conantokin-G, an N-methyl-D-aspartate (NMDA) antagonistP Chandler, M Pennington, M L Maccecchini, et al.
British Journal of Plastic Surgery|December 1, 1995
Free flaps in the management of intrathoracic sepsisD J Perkins, K K Lee, D G Pennington, et al.
Journal of Molecular Biology|October 20, 2010
Multiple global suppressors of protein stability defects facilitate the evolution of extended-spectrum TEM β-lactamasesNicholas G Brown, Jeanine M Pennington, Wanzhi Huang, et al.
Journal of Immunological Methods|January 1, 1982
A simple, single-step technique for selecting and cloning hybridomas for the production of monoclonal antibodiesJ M Davis, J E Pennington, A M Kubler, et al.
The Journal of Biological Chemistry|August 7, 1999
Protein kinase C and calcineurin synergize to activate IkappaB kinase and NF-kappaB in T lymphocytesS A Trushin, K N Pennington, A Algeciras-Schimnich, et al.
Geriatrics|August 19, 1999
Heart failure: clinical implications of systolic and diastolic dysfunctionM A Tecce, J A Pennington, B L Segal, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|November 22, 2002
Assessing human health response in life cycle assessment using ED10s and DALYs: part 2--Noncancer effectsDavid Pennington, Pierre Crettaz, Annick Tauxe, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
In vitro comparison of selected triple-drug combinations for suppression of HIV-1 replication: the Inter-Company Collaboration ProtocolM H St Clair, K N Pennington, J Rooney, et al.
Pageof 363